Formulation: Protein-Free
Denaturation
Reformulation
Protein-Free
Aggregation
Chemical Changes
Competitive Advantages:
No BSE or other pathogen concerns
Responsiveness to our customers
Applicable to multiple products
rFVIII, Influenza, Smallpox
Protein Excipient
Previous slide
Next slide
Back to first slide
View graphic version